Sales: $1.3 billion
Key Personnel: Pierre-Yves Revol, chairman of the Pierre Fabre Foundation; Bertrand Parmentier, group CEO; Eric Ducournau, CEO dermo-cosmetics division; Frédéric Duchesne, CEO pharmaceuticals division; Michael Danon, senior vice president, legal, pharmaceutical and public affairs; Thierry Denjean, senior vice president, human resources, ethics and sustainable development; Luc Péligry, senior vice president, finance and operations; Marc Alias, director, corporate communications; Olivier Siegler, director digital, processes and organization.
Major Products: Eau Thermale Avène, A-Derma, Galénic, Darrow (skin and body care), Ducray, Klorane, Glytone (skin and hair care), René Furterer (hair care), Elancyl (body care), Pierre Fabre Dermatologie (Rx and OTC).
New Products: Avène Hydrating Sun Care range; Klorane Dry shampoo with oat milk – natural tint; Glytone by Ducray Hair Loss range, Scaly Scalp range and Sensitive Scalp range; René Furterer Absolue Keratine range; Eau Thermale Avène XeraCalm A.D Lipid-Replenishing Cream, Balm and Cleansing Oil.
Comments: Pierre Fabre is the second largest dermo-cosmetics laboratory in the world and the second largest private French pharmaceutical group. In 2015, it generated more than €2.2 billion in sales, of which 57% came from its dermo-cosmetics sector, and 58% from international business. Pierre Fabre, which has always been based in the Languedoc Roussillon Midi Pyrenees region in southern France, has subsidiaries in 43 countries and distribution agreements in more than 130 countries.
Pierre Fabre employs 13,000 people worldwide. The company’s products represent a continuum ranging from prescription drugs, dermo-cosmetics, to consumer health care. In 2015, the company dedicated almost €200 million to R&D, shared between oncology, dermatology, the central nervous system, consumer health care and dermo-cosmetics.
Marketed globally, Eau Thermale Avène is the market-leading dermo-cosmetics brand in Europe, Japan and China.
The Pierre Fabre Foundation, a registered public interest foundation, is the Group’s main shareholder with 86% of its shares and Pierre Fabre employees own the majority of the remaining shares.
In 2015, the French certification group AFNOR audited Pierre Fabre Laboratories for its corporate social responsibility (CSR) and environmental performance, and judged the Group to be “exemplary” (AFAQ 26 000).